Retraction Note: SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-018-0875-3.
Main Authors: | Huaying Dong, Wei Wang, Shaowei Mo, Ru Chen, Kejian Zou, Jing Han, Fan Zhang, Jianguo Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | https://doi.org/10.1186/s13046-023-02596-2 |
Similar Items
-
SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88
by: Huaying Dong, et al.
Published: (2018-08-01) -
EIF4A3 stabilizes the expression of lncRNA AGAP2‐AS1 to activate cancer‐associated fibroblasts via MyD88/NF‐κb signaling
by: Qingqing Xu, et al.
Published: (2023-02-01) -
LncRNA NEAT1 activates MyD88/NF-κB pathway in bronchopneumonia through targeting miR-155-5p
by: Ling-jia Chen, et al.
Published: (2021-02-01) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
by: Wu Luo, et al.
Published: (2022-11-01) -
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
by: Junbin Chen, et al.
Published: (2020-06-01)